• Reduce GSK Pharma; target of Rs 2118: Dolat Capital

    ght86 Dolat Capital Accumulate PNC Infratech; target of Rs 113: Dolat Capital Accumulate Godrej Consumer; target of Rs 1605: Dolat Capital Buy Zensar Tech; target of Rs 1075: Dolat Capital Dolat Capital is bearish on GlaxoSmithKline Pharmaceuticals and has recommended reduce rating on the stock with a target of Rs 2118 in its November 9, […]

  • Hold DLF for long term: Amit Goyal

    Amit Goyal of Pace Group feels that one should hold DLF for long term. Goyal told CNBC-Awaaz, “Investors should hold DLF with a long term perspective.The stock is trading well in realty space but it is looking under pressure in short term. It can give attractive return in long term.” The company’s trailing 12-month (TTM) […]

  • Educomp likely to trade in Rs 230- 280 range: Tulsian

    SP Tulsian CEO | sptulsian.com Here are SP Tulsian’s top trading ideas Here are SP Tulsian’s top trading ideas Here are SP Tulsian’s top trading ideas Educomp Solutions is likely to trade in Rs 230- 280 range for next 1 to 2 months, says SP Tulsian, sptulsian.com. Tulsian told CNBC-TV18,

  • CRISIL retains valuation grade of 5/5 to Visaka Industries

    crisil_research CRISIL Research Union Budget 2017-2018 Review: CRISIL Conventional power to lag, renewable and T&D to perform: CRISIL Shriram Transport Finance – Poised for good growth: CRISIL CRISIL Research has come out with its report on Visaka Industries. The research firm has maintained the fundamental grade of 3/5 to the company in its November 11, […]

  • Nandurkar likes M&M with medium term perspective

    Mahesh Nandurkar Executive Director | CLSA Mahesh Nandurkar of CLSA likes M&M as a medium-term story. Nandurkar told CNBC-TV18, “M&M results have disappointed. We can’t go too much in for details because I haven’t seen much of details on that as yet. We have highlighted as a part of that report some of the themes […]